Nobuhiro Moro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nobuhiro Moro has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Atsuo Yoshino
Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
2 shared publications - David A. Hovda
Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA
2 shared publications - Neil G. Harris
Brain Injury Research Center, Department of Neurosurgery, David Geffen Medical School, University of California at Los Angeles, Los Angeles, California, 90095
2 shared publications - Sima S. Ghavim
Brain Injury Research Center, Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, Box 956901, CA, USA
2 shared publications Atsuo Yoshino
Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan
1 shared publication- Hiroshi Yagasaki
Pediatrics, Nihon University Itabashi Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- 22 January 2022
- Published by Elsevier in Brain Research Bulletin
- Vol. 181, 46-54
Anti-inflammatory effect of P2Y1 receptor blocker MRS2179 in a rat model of traumatic brain injury
- 22 January 2022
- Published by Elsevier in Brain Research Bulletin
- Vol. 181, 46-54
Anti-inflammatory effect of P2Y1 receptor blocker MRS2179 in a rat model of traumatic brain injury
- Open Access
- 31 March 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (6) , 1-10
Massive efflux of adenosine triphosphate into the extracellular space immediately after experimental traumatic brain injury
The aim of the current study was to determine effects of mild traumatic brain injury (TBI), with or without blockade of purinergic ATP Y1 (P2Y1) receptors or store‑operated calcium channels, on extracellular levels of ATP, glutamate, glucose and lactate. Concentrations of ATP, glutamate, glucose and lactate were measured in cerebral microdialysis samples obtained from the ipsilateral cortex and underlying hippocampus of rats with mild unilateral controlled cortical impact (CCI) or sham injury. Immediately after CCI, a large release of ATP was observed in the cortex (3.53‑fold increase of pre‑injury value) and hippocampus (2.97‑fold increase of pre‑injury value), with ATP returning to the baseline levels within 20 min post‑injury and remaining stable for during the 3‑h sampling period. In agreement with the results of previous studies, there was a significant increase in glutamate 20 min after CCI, which was concomitant with a decrease in extracellular glucose (20 min) and an increase in lactate (40‑60 min) in both brain regions after CCI. Addition of a selective P2Y1 receptor blocker (MRS2179 ammonium salt hydrate) to the microdialysis perfusate significantly lowered pre‑injury ATP and glutamate levels, and eliminated the post‑CCI peaks. Addition of a blocker of store‑operated calcium channels [2‑aminoethoxy diphenylborinate (2‑APB)] to the microdialysis perfusate significantly lowered pre‑injury ATP in the hippocampus, and attenuated the post‑CCI peak in both the cortex and hippocampus. 2‑APB treatment significantly increased baseline glutamate levels, but the values post‑injury did not differ from those in the sham group. Pre‑injury glucose levels, but not lactate levels, were increased by MRS2179 and decreased by 2‑APB. However, none of these treatments substantially altered the CCI‑induced reduction in glucose and increase in lactate in the cortex. In conclusion, the results of the present study demonstrated that a short although extensive release of ATP immediately after experimental TBI can be significantly attenuated by blockade of P2Y1 receptors or store‑operated calcium channels.
- 31 March 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (6) , 1-10
Open AccessMassive efflux of adenosine triphosphate into the extracellular space immediately after experimental traumatic brain injury
The aim of the current study was to determine effects of mild traumatic brain injury (TBI), with or without blockade of purinergic ATP Y1 (P2Y1) receptors or store‑operated calcium channels, on extracellular levels of ATP, glutamate, glucose and lactate. Concentrations of ATP, glutamate, glucose and lactate were measured in cerebral microdialysis samples obtained from the ipsilateral cortex and underlying hippocampus of rats with mild unilateral controlled cortical impact (CCI) or sham injury. Immediately after CCI, a large release of ATP was observed in the cortex (3.53‑fold increase of pre‑injury value) and hippocampus (2.97‑fold increase of pre‑injury value), with ATP returning to the baseline levels within 20 min post‑injury and remaining stable for during the 3‑h sampling period. In agreement with the results of previous studies, there was a significant increase in glutamate 20 min after CCI, which was concomitant with a decrease in extracellular glucose (20 min) and an increase in lactate (40‑60 min) in both brain regions after CCI. Addition of a selective P2Y1 receptor blocker (MRS2179 ammonium salt hydrate) to the microdialysis perfusate significantly lowered pre‑injury ATP and glutamate levels, and eliminated the post‑CCI peaks. Addition of a blocker of store‑operated calcium channels [2‑aminoethoxy diphenylborinate (2‑APB)] to the microdialysis perfusate significantly lowered pre‑injury ATP in the hippocampus, and attenuated the post‑CCI peak in both the cortex and hippocampus. 2‑APB treatment significantly increased baseline glutamate levels, but the values post‑injury did not differ from those in the sham group. Pre‑injury glucose levels, but not lactate levels, were increased by MRS2179 and decreased by 2‑APB. However, none of these treatments substantially altered the CCI‑induced reduction in glucose and increase in lactate in the cortex. In conclusion, the results of the present study demonstrated that a short although extensive release of ATP immediately after experimental TBI can be significantly attenuated by blockade of P2Y1 receptors or store‑operated calcium channels.
- Open Access
- 29 May 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 77
Unusual presentation of a skull base mass lesion in sarcoidosis mimicking malignant neoplasm: a case report
Sarcoidosis is a multi-organ disease of unknown etiology characterised by the presence of epithelioid granulomas, without caseous necrosis. Systemic sarcoidosis is rare among children, while neurosarcoidosis in children is even rarer whether it is systemic or not. We described the case of a 12-year-old boy who presented with monocular vision loss accompanied by unusual MRI features of an extensive meningeal infiltrating mass lesion. The patient underwent surgical resection (biopsy) via a frontotemporal craniotomy to establish a definitive diagnosis based on the histopathology, since neurosarcoidosis remains a very difficult diagnosis to establish from neuroradiogenic imagings. Based on the histopathology of the resected mass lesion, neurosarcoidosis was diagnosed. On follow-up after 3 months of steroid therapy, the patient displayed a good response on the imaging studies. MRI revealed that the preexisting mass lesion had regressed extremely. We also conducted a small literature review on imaging studies, manifestations, appropriate treatments, etc., in particular neurosarcoidosis including children. Although extremely rare, neurosarcoidosis, even in children, should be considered in the differential diagnosis of skull base mass lesions to avoid unnecessary aggressive surgery and delay in treatment, since surgery may have little role in the treatment of sarcoidosis.
- 29 May 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 77
Open AccessUnusual presentation of a skull base mass lesion in sarcoidosis mimicking malignant neoplasm: a case report
Sarcoidosis is a multi-organ disease of unknown etiology characterised by the presence of epithelioid granulomas, without caseous necrosis. Systemic sarcoidosis is rare among children, while neurosarcoidosis in children is even rarer whether it is systemic or not. We described the case of a 12-year-old boy who presented with monocular vision loss accompanied by unusual MRI features of an extensive meningeal infiltrating mass lesion. The patient underwent surgical resection (biopsy) via a frontotemporal craniotomy to establish a definitive diagnosis based on the histopathology, since neurosarcoidosis remains a very difficult diagnosis to establish from neuroradiogenic imagings. Based on the histopathology of the resected mass lesion, neurosarcoidosis was diagnosed. On follow-up after 3 months of steroid therapy, the patient displayed a good response on the imaging studies. MRI revealed that the preexisting mass lesion had regressed extremely. We also conducted a small literature review on imaging studies, manifestations, appropriate treatments, etc., in particular neurosarcoidosis including children. Although extremely rare, neurosarcoidosis, even in children, should be considered in the differential diagnosis of skull base mass lesions to avoid unnecessary aggressive surgery and delay in treatment, since surgery may have little role in the treatment of sarcoidosis.
- 25 January 2018
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 8 (3) , 466-470
Solitary primary intracranial leptomeningeal glioblastoma invading the normal cortex: Case report
Solitary primary intracranial leptomeningeal glioma (PLG) is a rare entity of glioma. PLG arises from the heterotopic glial tissue in the subarachnoid space and usually grows there without parenchymal invasion. The present study reported a case of solitary PLG, pathologically diagnosed as glioblastoma, that invaded the temporal cortex and finally disseminated to the spinal cord. A 55-year-old woman had headaches and visited Nihon University, Itabashi Hospital. Head magnetic resonance imaging showed a solid mass mainly located in the right middle fossa extending to the frontal base with strong enhancement effect after contrast medium injection. A conventional angiogram showed a tumor arising from the middle meningeal artery. Fronto-temporal craniotomy was performed to remove the tumor. During reflection of the dura matter, there were numerous small vessels connecting the dura matter and the cortical surface. The tumor was located in the Sylvian fissure and extended around the middle cerebral artery. The border between the tumor and the normal temporal lobe was unclear. Temporal lobectomy was done, but the tumor was left around the perforators of the middle cerebral artery. Hematoxylin and eosin staining showed typical glioblastoma with high cellularity, mitosis, pseudopallisading and vascular proliferation. The tumor cells were immunohistochemically negative for isocitrate dehydrogenase (IDH)1-R132H indicating glioblastoma, IDH-wild type. The patient received chemotherapy and radiation therapy, and was discharged from the hospital. Six months later, local regrowth and spinal dissemination were found. Despite additional chemotherapy and radiation therapy, the tumor became uncontrollable and the patient succumbed. Only 15 cases of solitary PLGs have been reported previously. The IDH status of these tumors have not been investigated in most cases; however, pathological grading varies from lower to higher grade glioma. Together with the pathological difference of astrocytic or oligodendrocytic tumors, solitary PLGs may develop due to various gene alterations similar to intra-axial gliomas.
- 25 January 2018
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 8 (3) , 466-470
Solitary primary intracranial leptomeningeal glioblastoma invading the normal cortex: Case report
Solitary primary intracranial leptomeningeal glioma (PLG) is a rare entity of glioma. PLG arises from the heterotopic glial tissue in the subarachnoid space and usually grows there without parenchymal invasion. The present study reported a case of solitary PLG, pathologically diagnosed as glioblastoma, that invaded the temporal cortex and finally disseminated to the spinal cord. A 55-year-old woman had headaches and visited Nihon University, Itabashi Hospital. Head magnetic resonance imaging showed a solid mass mainly located in the right middle fossa extending to the frontal base with strong enhancement effect after contrast medium injection. A conventional angiogram showed a tumor arising from the middle meningeal artery. Fronto-temporal craniotomy was performed to remove the tumor. During reflection of the dura matter, there were numerous small vessels connecting the dura matter and the cortical surface. The tumor was located in the Sylvian fissure and extended around the middle cerebral artery. The border between the tumor and the normal temporal lobe was unclear. Temporal lobectomy was done, but the tumor was left around the perforators of the middle cerebral artery. Hematoxylin and eosin staining showed typical glioblastoma with high cellularity, mitosis, pseudopallisading and vascular proliferation. The tumor cells were immunohistochemically negative for isocitrate dehydrogenase (IDH)1-R132H indicating glioblastoma, IDH-wild type. The patient received chemotherapy and radiation therapy, and was discharged from the hospital. Six months later, local regrowth and spinal dissemination were found. Despite additional chemotherapy and radiation therapy, the tumor became uncontrollable and the patient succumbed. Only 15 cases of solitary PLGs have been reported previously. The IDH status of these tumors have not been investigated in most cases; however, pathological grading varies from lower to higher grade glioma. Together with the pathological difference of astrocytic or oligodendrocytic tumors, solitary PLGs may develop due to various gene alterations similar to intra-axial gliomas.
- 1 July 2016
- Published by Elsevier in Brain Research
- Vol. 1642, 270-277
Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after experimental traumatic brain injury
- 1 July 2016
- Published by Elsevier in Brain Research
- Vol. 1642, 270-277
Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after experimental traumatic brain injury
- 1 October 2013
- Published by Elsevier in Brain Research
- Vol. 1535, 124-136
Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury
- 1 October 2013
- Published by Elsevier in Brain Research
- Vol. 1535, 124-136
Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury